Related Experiment Video
Updated: Aug 5, 2026

11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
ddOTs: A multiplexed quantitative ddPCR approach for resolving overlapping hepatitis B virus transcripts to decipher
Nazim Sarica1, Oceane Lopez1, João Diogo Dias1
1Institut de Génétique Humaine. Laboratoire de Virologie Moléculaire, Université de Montpellier, CNRS, Montpellier, France.
Plos Pathogens
|July 30, 2026
Summary
Hepatitis B virus (HBV) infection is a global health issue. A new ddPCR for Overlapping Transcripts (ddOTs) assay precisely quantifies HBV RNA, aiding research into viral transcription and drug development.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic Hepatitis B virus (HBV) infection is a major global health concern, leading to severe liver diseases like hepatocellular carcinoma.
- The viral minichromosome, covalently closed circular DNA (cccDNA), is crucial for HBV persistence and transcription.
- Quantifying HBV RNA is challenging due to overlapping viral open reading frames, hindering the understanding of transcriptional regulation.
Purpose of the Study:
- To develop a novel method for precise quantification of all major HBV RNA species, including splice variants.
- To overcome the limitations of existing methods in deconvoluting overlapping transcripts.
- To enable detailed analysis of cccDNA-driven transcription and facilitate antiviral drug development.
Main Methods:
- Development of a multiplexed assay, ddPCR for Overlapping Transcripts (ddOTs).
- Utilizing the high specificity and sensitivity of droplet digital PCR (ddPCR).
- Simultaneous quantification of diverse HBV RNA species from biological samples.
Main Results:
- The ddOTs assay successfully quantifies all major HBV RNA species with high specificity and sensitivity.
- The method effectively deconvolutes overlapping transcripts, overcoming previous quantification challenges.
- Demonstrated ability to interrogate individual promoter/enhancer activities and RNA stability.
Conclusions:
- The ddOTs assay provides a cost-effective and scalable solution for precise HBV RNA profiling.
- This breakthrough tool advances the study of cccDNA biology and HBV transcriptional regulation.
- Enables accelerated development of novel antiviral therapies for chronic HBV infection.

